PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Similar documents
PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Award Number: W81XWH

CONTRACTING ORGANIZATION: Western Institute For Biomedical Research Salt Lake City, UT

Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: University of California Lawrence Berkeley National Laboratory Berkeley, CA 94720

TITLE: New Advanced Technology to Improve Prediction and Prevention of Type 1 Diabetes

Approved for public release; distribution unlimited

Approved for public release; distribution unlimited

AWARD NUMBER: W81XWH TITLE: Gulf War Illness as a Brain Autoimmune Disorder. PRINCIPAL INVESTIGATOR: Apostolos Georgopoulos, MD, PhD

TITLE: Post-Traumatic Headache and Psychological Health: Mindfulness Training for Mild Traumatic Brain Injury

Award Number: W81XWH

TITLE: Demonstrating the Efficacy of Group Prolonged Exposure Treatment of PTSD in OEF/OIF/OND Male Veterans

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Maximizing Energy After Traumatic Brain Injury: A Novel Intervention

AD (Leave blank) TITLE: Brief cognitive behavioral therapy for military populations

TITLE: Computerized Tailored Interventions for Behavioral Sequelae of Post-Traumatic Stress Disorder in Veterans

CONTRACTING ORGANIZATION: Johns Hopkins Bloomberg School of Public Health

CONTRACTING ORGANIZATION: North Eastern Ohio Universities Rootstown OH 44202

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

AD (Leave blank) TITLE: Proteomic analyses of nipple fluid for early detection of breast cancer

AWARD NUMBER: W81XWH TITLE: Treatment of Pain and Autonomic Dysreflexia in Spinal Cord Injury with Deep Brain Stimulation

TITLE: Neural Protein Synuclein (SNCG) in Breast Cancer Progression

Award Number: W81XWH TITLE: Global Positioning Systems (GPS) Technology to Study Vector-Pathogen-Host Interactions

TITLE: 64Cu-DOTA-trastuzumab PET imaging in women with HER2 overexpressing breast cancer

Promote Adjustment during Reintegration following Deployment

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Dietary Genistein and Prostate Cancer Chemoprevention

CONTRACTING ORGANIZATION: Sloan-Kettering Institute for Cancer Research New York, NY 10021

Detection of Prostate Cancer Progression by Serum DNA Integrity

TITLE: Using Propranolol to Block Memory Reconsolidation in Female Veterans with PTSD

AD (Leave blank) Award Number: W81XWH TITLE: Targeting Autophagy for the Treatment of TSC and LAM. PRINCIPAL INVESTIGATOR: Elizabeth Henske

TITLE: Mission Connect Mild TBI Translational Research Consortium. U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Long Term Outcomes of BRCA1/BRCA2 Mutation Testing. CONTRACTING ORGANIZATION: Georgetown University Washington, DC

TITLE: Prazosin for Treatment of Patients With PTSD and Comorbid Alcohol Dependence

CONTRACTING ORGANIZATION: Veterans Medical Research Foundation San Diego, CA

TITLE: Improving Work Outcomes for Veterans with Traumatic Brain Injury. San Diego, CA 92161

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Award Number: W81XWH TITLE: "Longitudinal Study of a Novel Performance-based Measure of Daily Function."

TITLE: Short-Term Exercise and Prostate Cancer Prevention in African American Men. CONTRACTING ORGANIZATION: Howard University Washington DC 20059

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland X Approved for public release; distribution unlimited

CONTRACTING ORGANIZATION: Cold Spring Harbor Laboratory Cold Spring Harbor, NY 11724

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland Approved for public release; distribution unlimited

TITLE: Responsiveness of a Neuromuscular Recovery Scale for Spinal Cord Injury: Inpatient and Outpatient Rehabilitation

TITLE: Evaluation of DNA Methylation as a Target for Intraductal Therapy for Ductal Carcinoma in Situ of the Breast

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Page 1 AWARD NUMBER: W81XWH TITLE: A Novel Pleiotropic Anti-Inflammatory Drug to Reduce ARDS Incidence. PRINCIPAL INVESTIGATOR: Gary Nieman

TITLE: Breast Density Assessment by Dual Energy X-ray Absorptiometry in Women and Girls. Rachel Novotny, Ph.D. Honolulu, HI 96822

TITLE: Targeting the Immune System s Natural Response to Cell Death to Improve Therapeutic Response in Breast Cancers

AD (Leave blank) TITLE: Trial of Naltrexone and Dextromethorphan for Gulf War Veterans Illnesses

TITLE: Functional Genetics for Predisposition to Development of Type 2 Diabetes in Obese Individuals. PRINCIPAL INVESTIGATOR: Assia Shisheva

TITLE: Genes Associated with Food Allergy and Eosinophilic Esophagitis

CONTRACTING ORGANIZATION: Mount Sinai School of Medicine, New York, NY 10029

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Neural Markers and Rehabilitation of Executive Functioning in Veterans with TBI and PTSD

TITLE: MicroRNA in Prostate Cancer Racial Disparities and Aggressiveness

CONTRACTING ORGANIZATION: Memorial Sloan-Kettering Cancer Center New York, NY 10065

TITLE: Properties of Leukemia Stem Cells in a Novel Model of CML Progression to Lymphoid Blast Crisis

TITLE: Effect of Reminder Telephone Calls on Mammography Compliance in High Risk

TITLE: Determination of Optimum Vitamin D Nutrition in Young Women. Omaha, NE 68178

TITLE: Enhancing the Anti-Tumor Activity of ErbB Blockers with Histone Deaccetylase (HDAC) Inhibition in Prostate Cancer Cell Lines

TITLE: A Placebo-Controlled Augmentation Trial of Prazosin for Combat Trauma PTSD

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

RECIPIENT: Lankenau Institute for Medical Research, Wynnewood, PA 19096

AWARD NUMBER: W81XWH TITLE: Androgen Deprivation Therapy and Cognitive Impairment. PRINCIPAL INVESTIGATOR: Robert N. Pechnick, Ph.D.

TITLE: Identification of New Serum Biomarkers for Early Breast Cancer Diagnosis and Prognosis Using Lipid Microarrays.

CONTRACTING ORGANIZATION: Regents of the University of Michigan Ann Arbor, MI 48109

TITLE: Oxidative Stress, DNA Repair and Prostate Cancer Risk. PRINCIPAL INVESTIGATOR: Hua Zhao, Ph.D.

TITLE: Targeted Eradication of Prostate Cancer Mediated by Engineered Mesenchymal Stem Cells

TITLE: Effects of Tobacco Smoke (TS) on growth of clear cell renal cell carcinoma (ccrcc)

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: Spaulding Rehabilitation Hospital, Boston, MA 02129

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland Distribution Unlimited

CONTRACTING ORGANIZATION: Oregon Health & Science University Portland OR 97239

TITLE: Gulf War Illness Evaluation of an innovative detoxification program

CONTRACTING ORGANIZATION: The Trustees of Columbia University in City of New York New York, NY

Minneapolis Veterns Medical Center Minneapolis, MN 55417

CONTRACTING ORGANIZATION: Mount Sinai School of Medicine New York, New York

CONTRACTING ORGANIZATION: University of Minnesota St Paul, MN 55108

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Sphingosine-1-Phosphate Receptor Subtype 3: A Novel Therapeutic Target of K-Ras Mutant Driven Non-Small Cell Lung Carcinoma

CONTRACTING ORGANIZATION: The Henry M. Jackson Foundation (HJF) Bethesda, MD

TITLE: Homeostatic and Circadian Abnormalities in Sleep and Arousal in Gulf War Syndrome

TITLE: Estrogen-DNA Adducts as Novel Biomarkers for Ovarian Cancer Risk and for Use in Prevention

TITLE: Early Post Traumatic Seizures in Military Personnel Result in Long Term Disability

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: UNIVERSITY OF ILLINOIS Chicago, IL 60612

TITLE: A Phase II Trial of Androgen Suppression and Radiation Therapy with Samarium-1 53 in Localized, High-Risk, Prostate Cancer

TITLE: Establishing the Mineral Apposition Rate of Heterotopic Ossification for Prevention of Recurrence.

TITLE: "Impact of Obesity on Tamoxifen Chemoprevention in a Model of Ductal Carcinoma in Situ"

Co-PI: Amy Trentham-Dietz, PhD

TITLE: Role of ADAM15 in Tumor/Endothelial Interactions Prostate Cancer Regression

Award Number: W81XWH TITLE: A Novel Membrane-Permeable, Breast-Targeting, Pro-Apoptotic Peptide for Treatment of Breast Cancer

Award Number: MIPR 3GD3DN3081. TITLE: Outcomes of Telehealth Group Psychosocial Interventions for Breast Cancer Patients and Their Partners

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Proteomic Mapping of the Immune Response to Gluten in Children with Autism

TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer

Transcription:

AD Award Number: W81XWH-13-2-0021 TITLE: Basic Cognitive Neuroscience of Memory and Self-Appraisals in PTSD PRINCIPAL INVESTIGATOR: Charles R. Marmar, MD CONTRACTING ORGANIZATION: New York University New York, NY 10016-6402 REPORT DATE: February 2014 TYPE OF REPORT: Annual PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 DISTRIBUTION STATEMENT: Approved for Public Release; Distribution Unlimited The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation.

REPORT DOCUMENTATION PAGE Form Approved OMB No. 0704-0188 Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. 1. REPORT DATE 2. REPORT TYPE Annual 4. TITLE AND SUBTITLE Basic Cognitive Neuroscience of Memory and Self-Appraisals in PTSD 3. DATES COVERED 15 JAN 2013-14 JAN 2014 5a. CONTRACT NUMBER 5b. GRANT NUMBER W81XWH-13-2-0021 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) 5d. PROJECT NUMBER Charles R. Marmar, MD 5e. TASK NUMBER 5f. WORK UNIT NUMBER E-Mail: Charles.Marmar@nyumc.org 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBER New York University New York, NY 10016-6402 9. SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR S ACRONYM(S) U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 11. SPONSOR/MONITOR S REPORT NUMBER(S) 12. DISTRIBUTION / AVAILABILITY STATEMENT Approved for Public Release; Distribution Unlimited 13. SUPPLEMENTARY NOTES 14. ABSTRACT This proposal seeks to employ theories and paradigms from cognitive neuroscience to identify cognitive and neurobiological mechanisms underlying the relation between changes in self-efficacy (a core feature of self-identity) and combat-related PTSD. The discovery of such mechanisms will offer a novel means for conceptualizing PTSD, and will ultimately provide information that drives future research and therapeutic innovations informed directly by basic science, which in turn, may help to mitigate negative outcomes associated with PTSD. 15. SUBJECT TERMS Self-efficacy: one s perceived capacity to manage stressful life events. 16. SECURITY CLASSIFICATION OF: 17. LIMITATION OF ABSTRACT a. REPORT U b. ABSTRACT U 18. NUMBER OF PAGES c. THIS PAGE U UU 10 19a. NAME OF RESPONSIBLE PERSON USAMRMC 19b. TELEPHONE NUMBER (include area code)

Table of Contents Page Introduction..... 4 Body.. 4 Key Research Accomplishments... 9 Reportable Outcomes 9 Conclusion 9 References. 9

INTRODUCTION: Changes in self-identity are associated with a greater risk of PTSD, 1 poor treatment prognosis, 2 and suicidal ideation. 3 Combat appears to have a lasting impact on the identity of individuals deployed to war zones. This proposal seeks to employ theories and paradigms from cognitive neuroscience to identify cognitive and neurobiological mechanisms underlying the relation between changes in self-efficacy (a core feature of self-identity) and combat-related PTSD. The substantial number of individuals with PTSD that remain symptomatic post-treatment indicates the presence of pathological mechanisms that have yet to be examined or fully understood. Therefore, studies targeting the basic cognitive mechanisms and neurobiology of PTSD are a necessary first step in clarifying factors associated with risk in the onset and maintenance of PTSD. This study includes an analog and clinical phase (Phase 1 and Phase 2 respectively). In Phase 1, 120 healthy, civilian participants receive a self-efficacy induction, after which their affective responses to a trauma-film paradigm are monitored and their fear circuitry activation is examined using fmri. Phase 2 consists of 4 experiments with 300 OEF/OIF veterans examining their self-efficacy, autobiographical remembering, future imagining, anticipatory fear and emotional expression using both behavioral and neuroimaging paradigms. These findings have the potential to deliver information that drives future research in therapeutic innovations and resilience training informed directly by basic science, which in turn, may help to mitigate negative outcomes associated with combat-related PTSD. GOALS: The major goals of this study are: 1. Test whether increasing perception of self-efficacy reduces maladaptive cognitive and affective responses following exposure to a trauma film video. 2. Examine the neural basis of affect regulation by increasing perceptions of self-efficacy during fmri tasks among healthy control participants 3. Examine the cognitive processes and neural activation patters associated with memory and future thinking in PTSD 4. Examine the neural basis of affect regulation by increasing perceptions of self-efficacy during fmri tasks among OEF/OIF veterans with and without PTSD PROJECT ACCOMPLISHMENTS: The Basic Cognitive Neuroscience of Self-Appraisals and Memory in PTSD study has completed the development phase and is now in the implementation phase. In Year 1 of the grant we accomplished several milestones and goals outlined in the Statement of Work. Our success in meeting these goals is detailed below. 1. IRB 4

We secured IRB approval from all regulatory sites including NYU School of Medicine and the DOD. In addition the IRB protocols underwent amendments to reflect new provisions: Phase 1, Experiments 1 and 2: Eligible participants in Experiments 1 and 2 of Phase 1 are now asked to complete an online survey through the program Qualtrics Survey Software. Additionally, the online diary used in Experiment 1 of Phase 1 was replaced with a packet that participants can carry with them throughout the week. Phase 2, Experiments 2-4: Multiple validated, minimal risk self-report measures have been added to the protocol in order to enrich the dataset and better assess participants health status. Eligibility Criteria: The inclusion and exclusion requirements of controls and veterans have been modified; they are listed in the protocol. We ve modified the requirements to be consistent with the Steven and Alexandra Cohen Veterans Center for the Study for Post-Traumatic Stress Disorder and Traumatic Brain Injury recruitment protocol. All subjects participating in an MRI scan are required to provide a urine sample for drug testing and pregnancy testing (when applicable). Women who are pregnant are not allowed to partake in the MRI scan as it may be dangerous for the fetus. We also want to confirm that participants do not test positive for drugs as that may affect the neuroimaging results. This requirement is reflected in the protocol and consent forms. Informed Consent: Language used to describe the MRI scanning in both the consent form for controls and the consent form for veterans has been altered to comply with NYU's Center for Brain Imaging regulations. In addition, the consent forms for controls and veterans have been changed to specify that if participants are determined to be ineligible after their arrival to any of the MRI scanning sessions and thus do not complete the study, they will still be reimbursed $25.00 for their time. The consent form for veterans has also received a minor change- subjects that were recruited from previous studies conducted by the PTSD Research Program are given the option to release their clinical information from those studies to be used in the current one. This will decrease the burden on participants to provide duplicate information. Recruitment: The recruitment of controls now includes NYU and Sarah Lawrence College. In addition, controls are no longer limited to undergraduate students and the age range has been extended from 20-40 to 20-60 years old. The recruitment of veterans has been changed to include subjects from the Steven and Alexandra Cohen Veterans Center for the Study for Post-Traumatic Stress Disorder and Traumatic Brain Injury who have previously consented to be contacted for future studies. When our protocol was initially submitted for IRB approval, the Steven and Alexandra Cohen Veterans Center for the Study for Post-Traumatic Stress Disorder and Traumatic Brain Injury had not been established. The addition of subjects recruited from the Cohen Center study will aid in the recruitment and testing of participants. 5

Minor changes have also been made to the advertisements to better reflect what the experiments entail and they have been made into separate documents to receive IRB stamp of approval so that they may be distributed to potential participants. Personnel: The original PI, Dr. Adam Brown, was replaced with Dr. Charles Marmar. Dr. Adam Brown joined the faculty in the department of psychology at Sarah Lawrence College. He holds an adjunct assistant professorship at NYU School of Medicine, and continues to help oversee the project, but his new position no longer allows him to serve as a PI on grants at NYU. Other: The MRI Subject Screening Form is now given to all participants that have consented to an MRI scan has been added because NYU s Center for Brain Imaging requires that all subjects complete it. 2. Personnel The research team has been trained in all study procedures. In addition, the original PI, Dr. Adam Brown, was replaced with Dr. Charles Marmar. Dr. Adam Brown joined the faculty in the department of psychology at Sarah Lawrence College. He holds an adjunct assistant professorship at NYU School of Medicine, and continues to help oversee the project, but his new position no longer allows him to serve as a PI on grants at NYU. We have received IRB approval for this change. The research team meets weekly to review the study s progress. Dr. Brown speaks with the staff on a daily basis. Consultants are contacted as needed and are updated regularly on the progress of the study. 3. Subject Recruitment, Enrollment and Completion Healthy controls are currently being recruited and are participating in Experiments 1 and 2 of Phase 1. Veterans from the Biomarkers for PTSD study and the Steven and Alexandra Cohen Veterans Center for the Study for Post-Traumatic Stress Disorder and Traumatic Brain Injury are currently being recruited for Phase 2. We are running Experiment 1 of Phase 2 and preparing to implement Experiment 2 of Phase 2 in March 2014. The table below details current subject accrual data: Table 1. Subject Recruitment, Enrollment and Completion Data Experiment Recruited Screened Eligible 6 Ineligible Enrolled Phase 1, Exp. 1 90 58 42 16 26 18 Phase 1, Exp. 2 137 48 33 15 18 17 Total non-clinical 227 35 Completed

Phase 2, Exp. 1 51 51 48 Phase 2, Exp. 2 12 0 Phase 2, Exp. 3 0 Phase 2, Exp. 4 12 0 Total clinical 51 48 Total 83 4. Database Construction and Tracking A secure database has been developed. All clinical assessment data from the self-report and neurocognitive measures for all participants in Experiments 1 and 2 of Phase 1 and Experiment 1 of Phase 2 has been completed cleaned and entered as digital data directly into the study secure database server. Additionally, all neuroimaging data for all participants in Experiment 2 of Phase 1 has been transferred to the study secure database server and is being analyzed using the FSL neuroimaging software. 5. Acquisition of Study procedures Study procedures used in Experiments 1 and 2 of Phase 1 including MRI imaging, and Experiment 1 of Phase 2 are completely operational. 6. Standard Operating Procedure (SOP) Manuals SOPs have been developed for Experiments 1 and 2 of Phase 1, and Experiments 1-4 of Phase 2. 7. Preliminary Analysis Phase 1, Experiment 1: Currently 18 healthy volunteers have completed this experiment. Participants were randomly assigned to the High Self-Efficacy condition (N = 8), the Low Self-Efficacy condition (N = 7) and the Neutral Self-Efficacy condition (N = 3). The data has been entered into the study secure database server but has not been analyzed due to the fact that the subject pool is currently underpowered to report any group differences. Phase 1, Experiment 2: Analysis of neuroimaging data for 11 subjects has begun, and we have established that we are getting results that suggest that the paradigm is working and that we are successfully acquiring neuroimaging data. The experimental task exposes participants to time intervals when they may receive mild electrical shocks, and other intervals when they know they will not receive any shocks. Analysis of neuroimaging 7

data shows robust group-level activation in visual cortex in response to changing visual stimuli. Additional group means of interest include significant levels of deactivation in ventromedial PFC during the shock-related intervals. (This deactivation is also significantly lower than that seen in the non-shock-related trials) We have also begun to examine the effects of our self-efficacy induction on brain activity, but as yet have only six and five subjects in each group, and thus no significant differences to report. Phase 2, Experiment 1: OEF/OIF veterans were randomized to either a High Self Efficacy or Control condition. In the High Self Efficacy condition, individuals were asked to recall three autobiographical memories associated with success and selfefficacy. In the Control condition, participants recalled any three personally significant memories. After this task, participants completed a social problem-solving task. Specifically, participants listened to two military-related vignettes in which a protagonist is confronted with a specific problem or issue to be resolved. Based on the scoring system of the Means End Problem Solving Task (MEPS, Platt & Spivack, 1975) quantitative scores were computed for relevant means (discrete steps that enable the protagonist to move closer to the goal). In addition, qualitative scoring was also used to identify the subject's overall effectiveness, as well as the degree to which they statements incorporated agency-related content. Consistent with the hypothesis stated in the grant, preliminary analyses reveal that OEF/OIF individuals in the High Self-Efficacy condition preformed better on these three indices of social problem solving task (see results presented in Table 2). Table 2. Performance on the MEPS by High Self Efficacy or Control condition High Self Efficacy Condition Control Condition Variable M M MEPS - Mean 5.62 (2.58) 4.37 (1.61)** MEPS - Effectiveness 3.46 (0.93) 3.08 (0.88)* MEPS - Active Statements 3.83 (0.81) 3.46 (0.98)* MEPS = Means End Problem Solving Task. Mean = Number of solutions generated to solve problem. Effectives = Rating of overall quality of solutions generated for each strategy. Active Statements = Number of statements reflecting agency. **p <.05. *p <.15 OEF/OIF veterans in the High Self-Efficacy and Control condition were also asked to complete a Future Thinking Task. Participants were given 3 positive and 3 negative cue words and were asked to generate personally relevant imagined future events. Consistent with the hypothesis of this grant, OEF/OIF veterans in the High Self-Efficacy condition generated future events that reflect adaptive coping. For example, the future narratives generated by OEF/OIF individuals in the High Self Efficacy condition included a greater degree of agency-related statements, rated the future with a more positive outlook, and reported positive future events to be more central to their self-identity. Such findings suggest that selectively recalling self-efficacious memories promotes adaptive future thinking in OEF/OIF veterans. 8

Table 3. Performance on the Future Thinking Task by High Self Efficacy or Control condition High Self Efficacy Condition Control Condition Variable M M Future Thinking Agency 4.00 (.68) 3.59 (.95)* Future Thinking Positive Valence 4.00 (0.42) 3.7 (0.51)** Future Thinking Positive Centrality Statements 4.49 (0.61) 4.15 (0.92)* **p =.05. *p <.15 KEY RESEARCH ACCOMPLISHMENTS: Obtained IRB approvals across all sites and the DOD. Enrolled 28 healthy volunteers and 11 OIF/OEF veterans. Completed study procedures for 21 healthy volunteers and 47 OIF/OEF veterans. Research team participated in weekly study meetings. Entered, cleaned, and scored all data into a centralized database and ran reports for data analysis. Prepared preliminary analysis on a sample size of 47 OIF/OEF veterans. CONCLUSION: According to the Statement of Work, the tasks of months 1-12 of this study include: 1. Secure IRB approval from all regulatory sites (1-6 months) 2. Identify and Recruit (1-6 months) 3. Database Construction and Tracking (1-3 months) 4. Hire and Train Personnel (1-3 months) 5. Administer Analog Experiment 1 (months 6-12) The following tasks extend past year 1: 6. Administer Analog Experiment 2 (months 8-14) 7. Administer Clinical Experiment 1 (months 10-16) In year 1 of the project we completed tasks 1, 2, 3 and 4. We are currently administering Phase 1, Experiments 1 and 2 and Phase 2, Experiments 1 and 2. REFERENCES: 1. Ehlers A, Maercker A, Boos A. Post-traumatic stress disorder following political imprisonment: The role of mental defeat, alienation, and perceived permanent change. J Abnorm Psychol. 2000; 109: 45 55. 9

2. Ehlers A, Clark DM, Dunmore E, Jaycox L, Meadows E, Foa EB. Predicting response to exposure treatment in PTSD: The role of mental defeat and alienation. J Trauma Stress. 1998; 11: 457 471. 3. Brewin CR, Garnett R, Andrews B. Trauma, identity and mental health in UK military veterans. Psychol Med. 2010; 14:1-8. 4. Benight CC, Bandura A. Social cognitive theory of posttraumatic recovery: The role of perceived self-efficacy. Behaviour Research and Therapy. 2004; 42: 1129-1148. 10